SEC Form 4 · accession 0001209191-16-093447
LEMAITRE VASCULAR INC · LMAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cornelia W LeMaitre
Director
Period of report
Jan 21, 2016
Accepted (ET)
Jan 25, 2016 · 6:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001158895
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 16, 2015 | G | 1,575 | $0.00 | D | 181,020 | D | |
| Common StockF1 | Jan 21, 2016 | M | 2,001 | $7.87 | A | 183,021 | D | |
| Common StockF1 | Jan 21, 2016 | M | 2,289 | $6.67 | A | 185,310 | D | |
| Common StockF1 | Jan 21, 2016 | M | 1,307 | $6.23 | A | 186,617 | D | |
| Common StockF1 | Jan 21, 2016 | M | 1,098 | $7.10 | A | 187,715 | D | |
| Common StockF1 | Jan 21, 2016 | M | 1,143 | $5.85 | A | 188,858 | D | |
| Common Stock | Dec 21, 2015 | G | 6,400 | $0.00 | D | 220,481 | I | By spouse |
| Common StockF1 | Jan 21, 2016 | M | 2,001 | $7.87 | A | 222,482 | I | By spouse |
| Common StockF1 | Jan 21, 2016 | M | 2,289 | $6.67 | A | 224,771 | I | By spouse |
| Common StockF1 | Jan 21, 2016 | M | 1,307 | $6.23 | A | 226,078 | I | By spouse |
| Common StockF1 | Jan 21, 2016 | M | 1,098 | $7.10 | A | 227,176 | I | By spouse |
| Common StockF1 | Jan 21, 2016 | M | 1,143 | $5.85 | A | 228,319 | I | By spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $7.87 | Jan 21, 2016 | M | 2,001 | D | Jul 24, 2014 | Jul 24, 2021 | Common Stock | 2,001 | 8,002 | D |
| Stock Option (Right to Buy)F2 | $6.67 | Jan 21, 2016 | M | 2,289 | D | Jul 24, 2013 | Jul 24, 2020 | Common Stock | 2,289 | 6,866 | D |
| Stock Option (Right to Buy)F2 | $6.23 | Jan 21, 2016 | M | 1,307 | D | Jul 25, 2012 | Jul 25, 2019 | Common Stock | 1,307 | 2,612 | D |
| Stock Option (Right to Buy)F2 | $7.10 | Jan 21, 2016 | M | 1,098 | D | Jul 26, 2011 | Jul 26, 2018 | Common Stock | 1,098 | 1,099 | D |
| Stock Option (Right to Buy)F3 | $5.85 | Jan 21, 2016 | M | 1,143 | D | Jul 26, 2010 | Jul 26, 2017 | Common Stock | 1,143 | 0 | D |
| Stock Option (Right to Buy)F2 | $7.87 | Jan 21, 2016 | M | 2,001 | D | Jul 24, 2014 | Jul 24, 2021 | Common Stock | 2,001 | 8,002 | I |
| Stock Option (Right to Buy)F2 | $6.67 | Jan 21, 2016 | M | 2,289 | D | Jul 24, 2013 | Jul 24, 2020 | Common Stock | 2,289 | 6,866 | I |
| Stock Option (Right to Buy)F2 | $6.23 | Jan 21, 2016 | M | 1,307 | D | Jul 25, 2012 | Jul 25, 2019 | Common Stock | 1,307 | 2,612 | I |
| Stock Option (Right to Buy)F2 | $7.10 | Jan 21, 2016 | M | 1,098 | D | Jul 26, 2011 | Jul 26, 2018 | Common Stock | 1,098 | 1,099 | I |
| Stock Option (Right to Buy)F3 | $5.85 | Jan 21, 2016 | M | 1,143 | D | Jul 26, 2010 | Jul 26, 2017 | Common Stock | 1,143 | 0 | I |
Explanation of responses
- F1Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
- F2This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years
- F3This option is fully vested and exercisable.